TY - JOUR T1 - Amendment to '<em>Correction: Insights from immuno-oncology: the Society for Immunotherapy of Cancer Statement on access to IL-6-targeting therapies for COVID-19'</em> JF - Journal for ImmunoTherapy of Cancer JO - J Immunother Cancer DO - 10.1136/jitc-2020-000878corr1Amendment VL - 8 IS - 2 SP - e000878corr1Amendment A2 - , Y1 - 2020/08/01 UR - http://jitc.bmj.com/content/8/2/e000878corr1Amendment.abstract ER -